DNAPrint Genomics Inc. Reaches Payment Agreement With Dutchess Private Equities Fund, Ltd.

SARASOTA, FL--(MARKET WIRE)--Jul 31, 2007 -- DNAPrint® Genomics (OTC BB:DNAG.OB - News) today announced that it has reached a payment agreement with Dutchess Private Equities Fund, Ltd. (“Dutchess”) whereby approximately $6 million in notes and incentive debentures may be paid in full by the issuance of stock and warrants in connection with a proposed spin-off of DNAPrint’s wholly owned subsidiary, DNAPrint® Pharmaceuticals, Inc. (“Pharmaceuticals”).